MOH DG: New drugs have ‘marginal benefits’ MOH director-general Datuk Dr Noor Hisham Abdullah said the National Chemotherapy Protocol is revised from time to time and the latest revision is due for publication this year; he described it as a consensus guideline among oncologists and other specialists involved in cancer care.